Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
902.33
912.13
1,050.84
777.76
674.16
616.69
579.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
902.33
912.13
1,050.84
777.76
674.16
616.69
579.10
Raw Material Cost
746.56
768.32
922.11
641.34
518.64
471.13
439.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
75.75
70.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.29
6.68
6.03
4.16
1.04
1.99
3.32
Selling and Distribution Expenses
68.72
64.48
60.80
55.44
51.38
56.73
57.01
Other Expenses
1.96
2.83
2.61
2.19
1.95
-5.83
-5.62
Total Expenditure (Excl Depreciation)
842.13
867.74
1,015.07
722.83
590.56
547.29
513.30
Operating Profit (PBDIT) excl Other Income
60.199999999999996
44.400000000000006
35.8
54.900000000000006
83.6
69.4
65.8
Other Income
21.94
28.99
27.39
14.08
3.83
3.84
0.35
Operating Profit (PBDIT)
154.60
141.43
123.22
125.71
131.75
117.25
106.46
Interest
7.29
6.68
6.03
4.16
1.04
1.99
3.32
Exceptional Items
-6.51
-18.49
0.52
-0.32
1.08
1.64
-1.64
Gross Profit (PBDT)
155.77
143.81
128.73
136.42
155.52
145.56
139.99
Depreciation
68.68
68.72
60.25
45.01
30.99
30.08
25.89
Profit Before Tax
72.12
47.54
57.47
76.22
100.81
86.82
75.61
Tax
7.91
-3.02
-23.27
6.13
8.65
7.23
4.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
63.75
50.01
80.73
70.01
91.61
79.50
70.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
63.75
50.01
80.73
70.01
91.61
79.50
70.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
63.74
50.01
80.73
70.01
91.61
79.50
70.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,052.16
1,008.21
985.05
990.71
958.13
498.09
440.62
Earnings per share (EPS)
0.77
0.62
0.99
0.83
1.09
0.95
0.84
Diluted Earnings per share
0.77
0.62
0.99
0.83
1.09
0.95
0.84
Operating Profit Margin (Excl OI)
7.09%
4.79%
3.39%
8.57%
14.38%
13.51%
13.85%
Gross Profit Margin
15.6%
12.75%
11.2%
15.59%
19.55%
18.96%
17.53%
PAT Margin
7.06%
5.48%
7.68%
9.0%
13.59%
12.89%
12.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -1.07% vs -13.20% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 27.40% vs -38.04% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 18.06% vs 17.33% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 8.96% vs 11.67% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Zhejiang Dayang Biotech Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
902.33
0
902.33
Other Operating Income
0.00
0.00
0.00
Total Operating income
902.33
0
902.33
Raw Material Cost
746.56
0
746.56
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.29
0
7.29
Selling and Distribution Expenses
68.72
0
68.72
Other Expenses
1.96
0.00
1.96
Total Expenditure (Excl Depreciation)
842.13
0
842.13
Operating Profit (PBDIT) excl Other Income
60.20
0.00
60.20
Other Income
21.94
0
21.94
Operating Profit (PBDIT)
154.60
0
154.60
Interest
7.29
0
7.29
Exceptional Items
-6.51
0
-6.51
Gross Profit (PBDT)
155.77
0
155.77
Depreciation
68.68
0
68.68
Profit Before Tax
72.12
0
72.12
Tax
7.91
0
7.91
Provisions and contingencies
0
0
0.00
Profit After Tax
63.75
0
63.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
63.75
0
63.75
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.01
0
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
63.74
0
63.74
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,052.16
0
1,052.16
Earnings per share (EPS)
0.77
0
0.77
Diluted Earnings per share
0.77
0
0.77
Operating Profit Margin (Excl OI)
7.09%
0%
0.00
7.09%
Gross Profit Margin
15.60%
0%
0.00
15.60%
PAT Margin
7.06%
0%
0.00
7.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 90.23 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -1.07% vs -13.20% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 6.37 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 27.40% vs -38.04% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.27 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 18.06% vs 17.33% in Dec 2023
Annual - Interest
Interest 0.73 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 8.96% vs 11.67% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.09%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






